- George Stergiou, assistant professor of medicine,
- Thomas Mengden, assistant medical director, head of division,
- Paul L Padfield, consultant physician,
- Gianfranco Parati, associate professor of medicine,
- Eoin O'Brien, professor of cardiovascular pharmacology (eobrien@iol.ie)
- Hypertension Center, Third University Department of Medicine, Sotiria Hospital, 152 Mesogion Avenue, Athens 11527 Greece
- Division of Hypertension and Vascular Medicine, Medizinische Poliklinik, University Clinic Bonn, Wilhelmstrasse 35, D-5311 Bonn, Germany
- Department of Medical Sciences, Western General Hospital, Edinburgh EH4 2HU
- University of Milano-Bicocca, Cardiology II, S. Luca Hospital, via Spagnoletto, 3, 20149-Milan, Italy
- ADAPT Centre and Blood Pressure Unit, Beaumont Hospital and Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin 9, Ireland
Although measurement of blood pressure in the clinic is said to be the cornerstone of decision making in hypertension, such measurements may be unrepresentative of a patient's true blood pressure because of random fluctuations and the white coat effect.1–4 In addition, doctors rarely measure blood pressure according to recommended standards.4 Aimed at improving hypertension management, the 2003 US Joint National Committee recommends the use of self monitoring of blood pressure before considering the more expensive, but better validated ambulatory monitoring of blood pressure.2 Both the Joint National Committee and the 2003 guidelines from the European Society of Hypertension and the European Society of Cardiology suggest that self monitoring might also be used as an alternative to ambulatory monitoring for the diagnosis of white coat hypertension.1 2 The 2004 British Hypertension Society guidelines also acknowledge the increasing use of self monitoring in clinical practice and provide a threshold level for the diagnosis of hypertension (more than 135/85 mm Hg).3 In addition, two websites (www.bhssoc.org and www.dableducational.org) provide information on validated devices for self monitoring.
Cross sectional data and one outcome …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012